Geode Capital Management’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $810K | Buy |
290,255
+27,763
| +11% | +$94.4K | ﹤0.01% | 3429 |
|
|
2025
Q4 | $961K | Buy |
262,492
+18,071
| +7% | +$51.5K | ﹤0.01% | 3393 |
|
|
2025
Q3 | $904K | Buy |
244,421
+9,631
| +4% | +$24.4K | ﹤0.01% | 3413 |
|
|
2025
Q2 | $437K | Sell |
234,790
-2,744
| -1% | -$4.75K | ﹤0.01% | 3596 |
|
|
2025
Q1 | $371K | Buy |
237,534
+32,997
| +16% | +$58.2K | ﹤0.01% | 3654 |
|
|
2024
Q4 | $414K | Buy |
204,537
+35,930
| +21% | +$65.1K | ﹤0.01% | 3669 |
|
|
2024
Q3 | $244K | Buy |
168,607
+37,736
| +29% | +$71.9K | ﹤0.01% | 3844 |
|
|
2024
Q2 | $224K | Buy |
130,871
+17,554
| +15% | +$31.8K | ﹤0.01% | 3870 |
|
|
2024
Q1 | $227K | Buy |
113,317
+56,618
| +100% | +$113K | ﹤0.01% | 3899 |
|
|
2023
Q4 | $171K | Sell |
56,699
-3,328
| -6% | -$8.8K | ﹤0.01% | 3997 |
|
|
2023
Q3 | $261K | Buy |
60,027
+2,735
| +5% | +$18.8K | ﹤0.01% | 3873 |
|
|
2023
Q2 | $473K | Buy |
57,292
+10,740
| +23% | +$106K | ﹤0.01% | 3664 |
|
|
2023
Q1 | $573K | Buy |
46,552
+1,337
| +3% | +$15.9K | ﹤0.01% | 3588 |
|
|
2022
Q4 | $444K | Sell |
45,215
-102
| -0.2% | -$1.13K | ﹤0.01% | 3713 |
|
|
2022
Q3 | $584K | Buy |
45,317
+149
| +0.3% | +$2.23K | ﹤0.01% | 3640 |
|
|
2022
Q2 | $569K | Sell |
45,168
-39,640
| -47% | -$587K | ﹤0.01% | 3696 |
|
|
2022
Q1 | $1.73M | Sell |
84,808
-5,032
| -6% | -$138K | ﹤0.01% | 3328 |
|
|
2021
Q4 | $3.37M | Sell |
89,840
-905
| -1% | -$40.4K | ﹤0.01% | 3109 |
|
|
2021
Q3 | $4.38M | Buy |
90,745
+3,159
| +4% | +$154K | ﹤0.01% | 2985 |
|
|
2021
Q2 | $4.69M | Buy |
87,586
+9,555
| +12% | +$576K | ﹤0.01% | 2953 |
|
|
2021
Q1 | $4.13M | Buy |
78,031
+15,850
| +25% | +$894K | ﹤0.01% | 2883 |
|
|
2020
Q4 | $2.96M | Buy |
62,181
+3,054
| +5% | +$132K | ﹤0.01% | 2873 |
|
|
2020
Q3 | $3.58M | Buy |
59,127
+8,862
| +18% | +$451K | ﹤0.01% | 2578 |
|
|
2020
Q2 | $2.02M | Buy |
50,265
+27,187
| +118% | +$1.01M | ﹤0.01% | 2832 |
|
|
2020
Q1 | $654K | Sell |
23,078
-222
| -1% | -$7.37K | ﹤0.01% | 3185 |
|
|
2019
Q4 | $898K | Sell |
23,300
-198
| -0.8% | -$5.08K | ﹤0.01% | 3314 |
|
|
2019
Q3 | $496K | Sell |
23,498
-245
| -1% | -$5.76K | ﹤0.01% | 3471 |
|
|
2019
Q2 | $534K | Sell |
23,743
-9,433
| -28% | -$243K | ﹤0.01% | 3446 |
|
|
2019
Q1 | $885K | Buy |
33,176
+7,845
| +31% | +$206K | ﹤0.01% | 3207 |
|
|
2018
Q4 | $326K | Buy |
25,331
+2,882
| +13% | +$48.1K | ﹤0.01% | 3524 |
|
|
2018
Q3 | $538K | Buy |
22,449
+896
| +4% | +$28.7K | ﹤0.01% | 3436 |
|
|
2018
Q2 | $963K | Buy |
21,553
+1,406
| +7% | +$79.2K | ﹤0.01% | 3202 |
|
|
2018
Q1 | $1.38M | Buy |
20,147
+299
| +2% | +$18.9K | ﹤0.01% | 2966 |
|
|
2017
Q4 | $1.19M | Buy |
19,848
+204
| +1% | +$12K | ﹤0.01% | 3025 |
|
|
2017
Q3 | $1.3M | Buy |
19,644
+46
| +0.2% | +$3.1K | ﹤0.01% | 2998 |
|
|
2017
Q2 | $1.4M | Buy |
19,598
+360
| +2% | +$21.3K | ﹤0.01% | 2934 |
|
|
2017
Q1 | $1.07M | Buy |
19,238
+597
| +3% | +$26.7K | ﹤0.01% | 2986 |
|
|
2016
Q4 | $754K | Buy |
18,641
+521
| +3% | +$19.5K | ﹤0.01% | 3118 |
|
|
2016
Q3 | $807K | Buy |
18,120
+549
| +3% | +$23.3K | ﹤0.01% | 3060 |
|
|
2016
Q2 | $708K | Buy |
17,571
+2,219
| +14% | +$103K | ﹤0.01% | 3062 |
|
|
2016
Q1 | $713 | Sell |
15,352
-14
| -0.1% | -$591 | ﹤0.01% | 3053 |
|
|
2015
Q4 | $643K | Buy |
15,366
+658
| +4% | +$27.6K | ﹤0.01% | 3147 |
|
|
2015
Q3 | $573K | Buy |
+14,708
| New | +$687K | ﹤0.01% | 3165 |
|
|
2015
Q2 | – | Sell |
-14,720
| Closed | -$850K | – | 3973 |
|
|
2015
Q1 | $850K | Buy |
14,720
+2,143
| +17% | +$89.3K | ﹤0.01% | 2949 |
|
|
2014
Q4 | $460K | Buy |
12,577
+19
| +0.2% | +$560 | ﹤0.01% | 3233 |
|
|
2014
Q3 | $395K | Buy |
12,558
+4,640
| +59% | +$123K | ﹤0.01% | 3268 |
|
|
2014
Q2 | $204K | Sell |
7,918
-1,249
| -14% | -$32.9K | ﹤0.01% | 3517 |
|
|
2014
Q1 | $272K | Buy |
9,167
+2,634
| +40% | +$103K | ﹤0.01% | 3395 |
|
|
2013
Q4 | $257K | Buy |
6,533
+13
| +0.2% | +$502 | ﹤0.01% | 3342 |
|
|
2013
Q3 | $687K | Buy |
6,520
+352
| +6% | +$43.2K | ﹤0.01% | 2791 |
|
|
2013
Q2 | $796K | Buy |
+6,168
| New | +$909K | ﹤0.01% | 2603 |
|
Other funds holding FBIO
OM
VCM
SAM
GCP
BCM
Geode Capital Management's FBIO Position: Q1 2026 in Review
Geode Capital Management increased its Fortress Biotech (FBIO) stake by 11% in Q1 2026, buying an estimated $94.4K and bringing the position to 290,255 shares worth $810K. The position accounts for ﹤0.01% of the portfolio, ranked #3429.
Geode Capital Management first reported a position in FBIO in Q2 2013 and has held it in 51 quarters since. The position peaked at $4.69M in Q2 2021. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.
- Geode Capital Management held 290,255 shares of Fortress Biotech worth $810K as of Q1 2026.
- Geode Capital Management bought 27,763 Fortress Biotech shares in Q1 2026, an estimated $94.4K.
- Fortress Biotech made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3429 holding.
- Geode Capital Management first reported a position in Fortress Biotech in Q2 2013 and has held it in 51 quarters since.
- Geode Capital Management's Fortress Biotech position peaked at $4.69M in Q2 2021.
- 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.